loading
Schlusskurs vom Vortag:
$7.73
Offen:
$7.72
24-Stunden-Volumen:
269.59K
Relative Volume:
1.62
Marktkapitalisierung:
$163.96M
Einnahmen:
$66.59M
Nettoeinkommen (Verlust:
$-104.93M
KGV:
-1.5495
EPS:
-4.95
Netto-Cashflow:
$-96.48M
1W Leistung:
+16.39%
1M Leistung:
+6.82%
6M Leistung:
+48.07%
1J Leistung:
-47.75%
1-Tages-Spanne:
Value
$7.49
$7.89
1-Wochen-Bereich:
Value
$6.435
$8.11
52-Wochen-Spanne:
Value
$4.09
$15.92

Enanta Pharmaceuticals Inc Stock (ENTA) Company Profile

Name
Firmenname
Enanta Pharmaceuticals Inc
Name
Telefon
617 607 0800
Name
Adresse
4 KINGSBURY AVENUE, WATERTOWN, MA
Name
Mitarbeiter
131
Name
Twitter
@EnantaPharma
Name
Nächster Verdiensttermin
2025-02-10
Name
Neueste SEC-Einreichungen
Name
ENTA's Discussions on Twitter

Vergleichen Sie ENTA mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
ENTA
Enanta Pharmaceuticals Inc
7.67 140.87M 66.59M -104.93M -96.48M -4.95
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
470.13 119.21B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
560.93 59.16B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
325.28 40.57B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
571.23 34.02B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
295.59 29.19B 3.81B -644.79M -669.77M -6.24

Enanta Pharmaceuticals Inc Stock (ENTA) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2023-08-09 Herabstufung JP Morgan Neutral → Underweight
2023-08-08 Herabstufung Jefferies Buy → Hold
2022-12-09 Eingeleitet H.C. Wainwright Buy
2022-07-06 Hochstufung Evercore ISI In-line → Outperform
2022-06-01 Hochstufung Evercore ISI Underperform → In-line
2021-10-07 Eingeleitet Jefferies Buy
2021-09-09 Eingeleitet SVB Leerink Mkt Perform
2021-01-29 Hochstufung JP Morgan Underweight → Neutral
2020-11-24 Eingeleitet Evercore ISI Underperform
2020-08-28 Fortgesetzt ROTH Capital Buy
2020-08-26 Eingeleitet Piper Sandler Overweight
2020-07-27 Hochstufung JMP Securities Mkt Perform → Mkt Outperform
2020-03-17 Hochstufung Robert W. Baird Neutral → Outperform
2019-11-22 Herabstufung JMP Securities Mkt Outperform → Mkt Perform
2019-09-26 Herabstufung JP Morgan Neutral → Underweight
2019-05-24 Eingeleitet Wolfe Research Outperform
2019-04-23 Hochstufung Berenberg Hold → Buy
2018-12-13 Eingeleitet Berenberg Hold
2018-06-06 Eingeleitet ROTH Capital Buy
2018-02-08 Herabstufung JP Morgan Overweight → Neutral
2018-01-02 Herabstufung RBC Capital Mkts Outperform → Sector Perform
2017-11-21 Bestätigt RBC Capital Mkts Outperform
2017-09-15 Eingeleitet RBC Capital Mkts Outperform
2017-07-11 Hochstufung JMP Securities Mkt Perform → Mkt Outperform
2016-04-28 Herabstufung JMP Securities Mkt Outperform → Mkt Perform
2016-02-09 Bestätigt Barclays Underweight
2015-10-23 Herabstufung Barclays Equal Weight → Underweight
2015-10-23 Hochstufung JMP Securities Mkt Perform → Mkt Outperform
Alle ansehen

Enanta Pharmaceuticals Inc Aktie (ENTA) Neueste Nachrichten

pulisher
03:35 AM

What drives Enanta Pharmaceuticals Inc. stock priceTriple-digit growth rates - Autocar Professional

03:35 AM
pulisher
Jul 22, 2025

What analysts say about Enanta Pharmaceuticals Inc. stockPhenomenal wealth increase - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Is Enanta Pharmaceuticals Inc. a good long term investmentHigh-yield capital appreciation - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Enanta Pharmaceuticals Inc. Stock Analysis and ForecastConsistent wealth multiplication - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Enanta Pharmaceuticals at Baird’s Biotech: Strategic Virology and Immunology Shift - Investing.com Canada

Jul 22, 2025
pulisher
Jul 18, 2025

why enanta pharmaceuticals inc. stock attracts strong analyst attentionShort Term Risk Controlled Alerts - Newser

Jul 18, 2025
pulisher
Jul 18, 2025

Will Enanta Pharmaceuticals Inc. stock benefit from interest rate changesFast Growing Stocks - Newser

Jul 18, 2025
pulisher
Jul 16, 2025

Enanta Pharmaceuticals to Participate in Baird’s Biotech Discovery Series - BioSpace

Jul 16, 2025
pulisher
Jul 16, 2025

how enanta pharmaceuticals inc. stock performs during market volatilityFree Smart Investment Opportunities - Newser

Jul 16, 2025
pulisher
Jul 16, 2025

What makes Enanta Pharmaceuticals Inc. stock price move sharplyBreakout Momentum Stocks - Newser

Jul 16, 2025
pulisher
Jul 15, 2025

How Enanta Pharmaceuticals Inc. stock performs during market volatilityFree Investment Community - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Why Enanta Pharmaceuticals Inc. stock attracts strong analyst attentionVolume Spike Monitors - Newser

Jul 15, 2025
pulisher
Jul 12, 2025

(ENTA) On The My Stocks Page - news.stocktradersdaily.com

Jul 12, 2025
pulisher
Jul 10, 2025

Enanta Pharmaceuticals Insider Buyers Net US$65k Despite 11% Stock Decline - simplywall.st

Jul 10, 2025
pulisher
Jun 21, 2025

(ENTA) Technical Pivots with Risk Controls - news.stocktradersdaily.com

Jun 21, 2025
pulisher
Jun 14, 2025

Enanta Pharmaceuticals’ SWOT analysis: stock shifts focus to immunology amid RSV progress - Investing.com Nigeria

Jun 14, 2025
pulisher
Jun 12, 2025

ENTA’s Market Quandary: Decoding the Ups and Downs of 2023 - investchronicle.com

Jun 12, 2025
pulisher
Jun 11, 2025

FDA Expands AbbVie's Mavyret Label To Include Acute Hepatitis C Treatment (CORRECTED) - Benzinga

Jun 11, 2025
pulisher
Jun 11, 2025

FDA Expands AbbVie's Mavyret Label To Include Acute Hepatitis C Treatment (CORRECTED) - Benzinga

Jun 11, 2025
pulisher
Jun 11, 2025

AbbVie wins FDA nod for Mavyret label expansion (ABBV:NYSE) - Seeking Alpha

Jun 11, 2025
pulisher
Jun 11, 2025

Enanta Pharmaceuticals' Partner AbbVie Receives U.S. FDA Approva - GuruFocus

Jun 11, 2025
pulisher
Jun 11, 2025

Enanta Pharmaceuticals’ Partner AbbVie Receives U.S. FDA Approval of an Expanded Indication for MAVYRET® (glecaprevir/pibrentasvir) as the First and Only Treatment for People with Acute Hepatitis C Virus - Yahoo Finance

Jun 11, 2025
pulisher
Jun 10, 2025

(ENTA) Proactive Strategies - news.stocktradersdaily.com

Jun 10, 2025
pulisher
Jun 04, 2025

Enanta Pharmaceuticals (NASDAQ:ENTA) Given New $24.00 Price Target at JMP Securities - Defense World

Jun 04, 2025
pulisher
Jun 03, 2025

Enanta Pharma (ENTA) Receives Target Price Boost from JMP Securi - GuruFocus

Jun 03, 2025
pulisher
Jun 03, 2025

Enanta (ENTA) Price Target Raised as Key Clinical Results Antici - GuruFocus

Jun 03, 2025
pulisher
Jun 03, 2025

Enanta (ENTA) Price Target Raised as Key Clinical Results Anticipated | ENTA Stock News - GuruFocus

Jun 03, 2025
pulisher
Jun 03, 2025

Citizens JMP raises Enanta Pharmaceuticals stock price target to $24 By Investing.com - Investing.com UK

Jun 03, 2025
pulisher
May 27, 2025

Enanta Pharmaceuticals to Present at the Jefferies Global Healthcare Conference - BioSpace

May 27, 2025

Finanzdaten der Enanta Pharmaceuticals Inc-Aktie (ENTA)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$21.80
price up icon 0.51%
$36.10
price up icon 1.26%
$102.92
price up icon 0.14%
$26.54
price up icon 0.76%
$111.44
price up icon 2.32%
biotechnology ONC
$295.59
price up icon 1.25%
Kapitalisierung:     |  Volumen (24h):